Free Trial
→ Crypto bros: Meet your replacement (From Brownstone Research) (Ad) Free ABT Stock Alerts

Abbott Laboratories (ABT) Short Interest Ratio & Short Volume

Abbott Laboratories logo
$133.10 +1.05 (+0.79%)
As of 10:35 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Abbott Laboratories Short Interest Data

Abbott Laboratories (ABT) has a short interest of 19.06 million shares, representing 1.10% of the float (the number of shares available for trading by the public). This marks a -1.90% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.8, indicating that it would take 2.8 days of the average trading volume of 6.86 million shares to cover all short positions.

Current Short Interest
19,060,000 shares
Previous Short Interest
19,430,000 shares
Change Vs. Previous Month
-1.90%
Dollar Volume Sold Short
$2.50 billion
Short Interest Ratio
2.8 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
1,740,459,000 shares
Float Size
1,730,000,000 shares
Short Percent of Float
1.10%
Today's Trading Volume
1,312,609 shares
Average Trading Volume
6,863,530 shares
Today's Volume Vs. Average
19%
Short Selling Abbott Laboratories?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Abbott Laboratories and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ABT Short Interest Over Time

ABT Days to Cover Over Time

ABT Percentage of Float Shorted Over Time

Abbott Laboratories Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202519,060,000 shares $2.50 billion -1.9%1.1%2.8 $131.41
6/30/202519,430,000 shares $2.64 billion -6.6%1.1%2.9 $136.09
6/15/202520,800,000 shares $2.82 billion +3.5%1.2%3.1 $135.41
5/31/202520,090,000 shares $2.69 billion -9.8%1.2%2.9 $133.68
5/15/202522,260,000 shares $2.97 billion +5.4%1.3%3.1 $133.39
4/30/202521,120,000 shares $2.76 billion -2.6%1.2%3 $130.71
4/15/202521,690,000 shares $2.73 billion -0.5%1.3%2.9 $126.08
3/31/202521,790,000 shares $2.89 billion -0.4%1.3%3.1 $132.76
3/15/202521,880,000 shares $2.78 billion -4.6%1.3%3.3 $127.02
2/28/202522,930,000 shares $3.16 billion +2.8%1.3%3.7 $137.99
2/15/202522,310,000 shares $2.91 billion +22.3%1.3%3.9 $130.63
1/31/202518,240,000 shares $2.33 billion +21.8%1.1%3.2 $127.69
1/15/202514,970,000 shares $1.66 billion +4.5%0.9%2.7 $110.96
12/31/202414,320,000 shares $1.62 billion +18.4%0.8%2.9 $113.11
12/15/202412,100,000 shares $1.37 billion -10.8%0.7%2.4 $113.38
11/30/202413,570,000 shares $1.61 billion +12.6%0.8%2.7 $118.77
11/15/202412,050,000 shares $1.40 billion -14.4%0.7%2.4 $115.90
10/31/202414,070,000 shares $1.60 billion +0.6%0.8%2.9 $113.39
10/15/202413,980,000 shares $1.62 billion +18.2%0.8%2.5 $116.04
9/30/202411,830,000 shares $1.35 billion -11.5%0.7%2 $114.01
9/15/202413,360,000 shares $1.56 billion +4.8%0.8%2.2 $116.40
8/31/202412,750,000 shares $1.44 billion +0.6%0.7%2.1 $113.27
8/15/202412,680,000 shares $1.41 billion -7.0%0.7%2 $110.95
7/31/202413,630,000 shares $1.44 billion +26.8%0.8%2 $105.96
7/15/202410,750,000 shares $1.11 billion -17.3%0.6%1.8 $102.99
6/30/202413,000,000 shares $1.35 billion +11.9%0.8%2.3 $103.91
6/15/202411,620,000 shares $1.20 billion -19.9%0.7%2 $103.68
5/31/202414,500,000 shares $1.48 billion -1.8%0.8%2.4 $102.22
5/15/202414,770,000 shares $1.54 billion +2.0%0.9%2.6 $104.56
4/30/202414,480,000 shares $1.53 billion +11.9%0.8%2.6 $105.94
4/15/202412,940,000 shares $1.41 billion -10.6%0.8%2.2 $108.89
3/31/202414,480,000 shares $1.65 billion -7.9%0.8%2.5 $113.66
3/15/202415,720,000 shares $1.80 billion +5.4%0.9%2.9 $114.43
2/29/202414,920,000 shares $1.77 billion +4.4%0.9%3 $118.56
2/15/202414,290,000 shares $1.62 billion +12.5%0.8%2.7 $113.64
1/31/202412,700,000 shares $1.44 billion +20.4%0.7%2.3 $113.16
1/15/202410,550,000 shares $1.20 billion -11.2%0.6%1.9 $113.92
12/31/202311,880,000 shares $1.31 billion -3.5%0.7%2 $110.07
12/15/202312,310,000 shares $1.32 billion +4.8%0.7%2 $107.29
11/30/202311,750,000 shares $1.23 billion -2.7%0.7%2 $104.30
GENIUS Act: Cancel Your Money? (Ad)

A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.

Get the free info kit with 3 strategies to sidestep digital dollar control.
11/15/202312,080,000 shares $1.18 billion +22.3%0.7%2.2 $98.00
10/31/20239,880,000 shares $934.15 million +1.9%0.6%1.9 $94.55
10/15/20239,700,000 shares $881.44 million -4.7%0.6%2 $90.87
9/30/202310,180,000 shares $985.93 million -4.1%0.6%2.3 $96.85
9/15/202310,610,000 shares $1.08 billion -7.5%0.6%2.4 $101.76
8/31/202311,470,000 shares $1.18 billion -10.2%0.7%2.5 $102.90
8/15/202312,770,000 shares $1.34 billion +6.0%0.7%2.6 $104.93
7/31/202312,050,000 shares $1.34 billion +9.4%0.7%2.5 $111.34
7/15/202311,020,000 shares $1.19 billion -16.6%0.6%2.3 $107.93
6/30/202313,220,000 shares $1.44 billion +11.8%0.8%2.7 $109.02
6/15/202311,820,000 shares $1.24 billion -12.0%0.7%2.3 $105.04
5/31/202313,430,000 shares $1.37 billion +3.7%0.8%2.6 $102.00
5/15/202312,950,000 shares $1.42 billion +15.2%0.8%2.5 $109.84
4/30/202311,240,000 shares $1.24 billion -10.8%0.7%2.1 $110.47
4/15/202312,600,000 shares $1.31 billion No Change0.7%2.3 $103.96
3/31/202312,600,000 shares $1.28 billion -1.9%0.7%2.4 $101.26
3/15/202312,840,000 shares $1.26 billion -7.8%0.7%2.6 $97.80
2/28/202313,930,000 shares $1.42 billion +5.6%0.8%2.9 $101.72
2/15/202313,190,000 shares $1.42 billion +9.9%0.8%2.8 $107.28
1/31/202312,000,000 shares $1.33 billion -17.8%0.7%2.5 $110.55
1/15/202314,600,000 shares $1.66 billion -12.5%0.8%2.8 $113.51
12/30/202216,680,000 shares $1.83 billion -7.8%1.0%3 $109.79
12/15/202218,090,000 shares $1.96 billion +14.9%1.1%3.1 $108.52
11/30/202215,740,000 shares $1.69 billion +0.6%0.9%2.6 $107.58
11/15/202215,650,000 shares $1.61 billion +10.3%0.9%2.6 $103.14
10/31/202214,190,000 shares $1.40 billion +1.4%0.8%2.5 $98.94
10/15/202213,990,000 shares $1.41 billion -16.9%0.8%2.6 $100.91
9/30/202216,830,000 shares $1.63 billion +5.0%1.0%3.5 $96.76
9/15/202216,030,000 shares $1.68 billion +23.9%0.9%3.4 $105.06
8/31/202212,940,000 shares $1.33 billion -8.1%0.7%2.7 $102.65
8/15/202214,080,000 shares $1.58 billion +1.7%0.8%3 $111.90
7/31/202213,840,000 shares $1.51 billion -2.7%0.8%2.7 $108.84
7/15/202214,220,000 shares $1.55 billion +9.6%0.8%2.6 $108.82
6/30/202212,980,000 shares $1.41 billion -7.4%0.8%2.4 $108.65
6/15/202214,020,000 shares $1.47 billion +2.6%0.8%2.6 $104.80
5/31/202213,670,000 shares $1.61 billion +0.7%0.8%2.6 $117.46
5/15/202213,570,000 shares $1.49 billion +0.8%0.8%2.4 $109.88
4/30/202213,460,000 shares $1.53 billion +5.2%0.8%2.5 $113.50
4/15/202212,790,000 shares $1.51 billion +5.7%0.7%2.1 $117.69
3/31/202212,100,000 shares $1.43 billion -9.2%0.7%2 $118.36
3/15/202213,330,000 shares $1.57 billion +28.4%0.8%2.2 $117.48
2/28/202210,380,000 shares $1.25 billion +0.1%0.6%1.6 $120.62
2/15/202210,370,000 shares $1.29 billion +15.4%0.6%1.7 $123.98
1/31/20228,990,000 shares $1.15 billion -0.2%0.5%1.5 $127.46
1/15/20229,010,000 shares $1.15 billion +7.4%0.5%1.6 $128.16
12/31/20218,390,000 shares $1.18 billion -13.3%0.5%1.6 $140.74
12/15/20219,680,000 shares $1.31 billion +11.1%0.6%1.8 $135.56
11/30/20218,710,000 shares $1.10 billion -14.1%0.5%1.7 $125.77
11/15/202110,140,000 shares $1.31 billion -9.7%0.6%2 $129.44
10/29/202111,230,000 shares $1.45 billion +7.0%N/A2.3 $128.89
GENIUS Act: Cancel Your Money? (Ad)

A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.

Get the free info kit with 3 strategies to sidestep digital dollar control.
10/15/202110,500,000 shares $1.23 billion -6.4%0.6%2.3 $117.49
9/30/202111,220,000 shares $1.33 billion +1.5%0.6%2.4 $118.13
9/15/202111,050,000 shares $1.41 billion +8.1%0.6%2.4 $127.49
8/31/202110,220,000 shares $1.29 billion -7.0%0.6%2.1 $126.37
8/13/202110,990,000 shares $1.35 billion -8.0%0.6%1.8 $123.06
7/30/202111,940,000 shares $1.44 billion +2.8%0.7%2 $120.98
7/15/202111,620,000 shares $1.36 billion -14.2%0.7%1.9 $116.66
6/30/202113,550,000 shares $1.57 billion -3.3%0.8%2.2 $115.93
6/15/202114,010,000 shares $1.55 billion -3.8%0.8%2.3 $110.41
5/28/202114,570,000 shares $1.70 billion +2.6%0.8%2.5 $116.65
5/14/202114,200,000 shares $1.67 billion +1.5%N/A2.9 $117.45
4/30/202113,990,000 shares $1.69 billion -4.2%N/A2.8 $121.01
4/15/202114,600,000 shares $1.77 billion +7.0%N/A2.8 $121.50
3/31/202113,640,000 shares $1.63 billion +7.2%N/A2.6 $119.75
3/15/202112,730,000 shares $1.49 billion +30.0%N/A2.5 $116.71
2/26/20219,790,000 shares $1.19 billion -6.7%N/A1.9 $121.58
2/12/202110,490,000 shares $1.33 billion -8.9%N/A2.1 $126.84
1/29/202111,520,000 shares $1.39 billion +29.4%N/A2.3 $120.39
1/15/20218,900,000 shares $979.36 million -10.5%N/A1.8 $110.04
12/31/20209,940,000 shares $1.08 billion +11.9%N/A2.1 $108.44
12/15/20208,880,000 shares $948.30 million -9.1%N/A1.8 $106.79
11/30/20209,770,000 shares $1.05 billion -17.6%N/A2 $107.62
11/15/202011,850,000 shares $1.33 billion +19.5%N/A2.1 $112.60
10/30/20209,920,000 shares $1.04 billion +5.6%N/A1.8 $105.00
10/15/20209,390,000 shares $1.01 billion -0.5%N/A1.8 $107.75
9/30/20209,440,000 shares $1.03 billion +8.8%N/A1.8 $108.83
9/15/20208,680,000 shares $925.11 million -16.5%N/A1.6 $106.58
8/31/202010,400,000 shares $1.14 billion +3.1%N/A1.9 $109.47
8/14/202010,090,000 shares $1.01 billion -20.6%N/A2 $99.99

ABT Short Interest - Frequently Asked Questions

What is Abbott Laboratories' current short interest?

Short interest is the volume of Abbott Laboratories shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 19,060,000 shares of ABT short. 1.10% of Abbott Laboratories' shares are currently sold short. Learn More on Abbott Laboratories' current short interest.

What is a good short interest ratio for Abbott Laboratories?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABT shares currently have a short interest ratio of 3.0. Learn More on Abbott Laboratories's short interest ratio.

Which institutional investors are shorting Abbott Laboratories?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Abbott Laboratories: Garda Capital Partners LP, Simplex Trading LLC, Bank of Montreal Can, Wolverine Asset Management LLC, Allianz Asset Management GmbH, Quaker Wealth Management LLC, Jane Street Group LLC, Parallax Volatility Advisers L.P., Millennium Management LLC, Caption Management LLC, Nomura Holdings Inc., Susquehanna International Group LLP, HAP Trading LLC, BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Garda Capital Partners LP, Credit Agricole S A, Maven Securities LTD, Arrowpoint Investment Partners Singapore Pte. Ltd., Simplex Trading LLC, JPMorgan Chase & Co., Locust Wood Capital Advisers LLC, Wolverine Asset Management LLC, Citigroup Inc., and XY Capital Ltd. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Abbott Laboratories?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.10% of Abbott Laboratories' floating shares are currently sold short.

Is Abbott Laboratories' short interest increasing or decreasing?

Abbott Laboratories saw a decline in short interest in July. As of July 15th, there was short interest totaling 19,060,000 shares, a decline of 1.9% from the previous total of 19,430,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Abbott Laboratories' float size?

Abbott Laboratories currently has issued a total of 1,740,459,000 shares. Some of Abbott Laboratories' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Abbott Laboratories currently has a public float of 1,730,000,000 shares.

How does Abbott Laboratories' short interest compare to its competitors?

1.10% of Abbott Laboratories' shares are currently sold short. Here is how the short interest of companies compare to Abbott Laboratories: DexCom, Inc. (2.27%), Intuitive Surgical, Inc. (1.08%), Tesla, Inc. (2.17%), AbbVie Inc. (0.89%), Boston Scientific Corporation (1.32%), Elevance Health, Inc. (1.21%), Integer Holdings Corporation (7.48%), Johnson & Johnson (0.76%), Medtronic PLC (1.02%), Thermo Fisher Scientific Inc. (1.02%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short Abbott Laboratories stock?

Short selling ABT is an investing strategy that aims to generate trading profit from Abbott Laboratories as its price is falling. ABT shares are trading up $1.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Abbott Laboratories?

A short squeeze for Abbott Laboratories occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABT, which in turn drives the price of the stock up even further.

How often is Abbott Laboratories' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABT, twice per month. The most recent reporting period available is July, 15 2025.



Related Companies
Short Interest Tools

This page (NYSE:ABT) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners
Altucher: Trump’s Great Gain is starting
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...
Paradigm Press | Sponsored
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Crypto 101 Media | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...
Weiss Ratings | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...
Brownstone Research | Sponsored
Critical AI announcement set to ignite AI 2.0
A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...
Timothy Sykes | Sponsored
Trump’s new nightmare
According to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...
Porter & Company | Sponsored